APA (7th ed.) Citation

Roufosse, F. E., Kahn, J., Gleich, G. J., Schwartz, L. B., Singh, A. D., Rosenwasser, L. J., . . . Klion, A. D. (2013). Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromes. Journal of allergy and clinical immunology, 131(2), 461-467.e5. https://doi.org/10.1016/j.jaci.2012.07.055

Chicago Style (17th ed.) Citation

Roufosse, Florence E., et al. "Long-term Safety of Mepolizumab for the Treatment of Hypereosinophilic Syndromes." Journal of Allergy and Clinical Immunology 131, no. 2 (2013): 461-467.e5. https://doi.org/10.1016/j.jaci.2012.07.055.

MLA (9th ed.) Citation

Roufosse, Florence E., et al. "Long-term Safety of Mepolizumab for the Treatment of Hypereosinophilic Syndromes." Journal of Allergy and Clinical Immunology, vol. 131, no. 2, 2013, pp. 461-467.e5, https://doi.org/10.1016/j.jaci.2012.07.055.